返回
PubChem 2025 update
DOI:10.1093/nar/gkae1059.png)
摘要
En 中文
PubChem ( https://pubchem.ncbi.nlm.nih.gov) is a large and highly-integrated public chemical database resource at NIH. In the past two years, significant updates were made to PubChem. With additions from over 130 new sources, PubChem contains > 1000 data sources, 119 million compounds, 322 million substances and 295 million bioactivities. New interfaces, such as the consolidated literature panel and the patent knowledge panel, were developed. The consolidated literature panel combines all references about a compound into a single list, allowing users to easily find, sort, and export all relevant articles for a chemical in one place. The patent knowledge panels for a given query chemical or gene display chemicals, genes, and diseases co-mentioned with the query in patent documents, helping users to explore relationships between cooccurring entities within patent documents. PubChemRDF was expanded to include the co-occurrence data underlying the literature knowledge panel, enabling users to exploit semantic web technologies to explore entity relationships based on the co-occurrences in the scientific literature. The usability and accessibility of information on chemicals with non-discrete structures (e.g. biologics, minerals, polymers, UVCBs and glycans) were greatly improved with dedicated web pages that provide a comprehensive view of all available information in PubChem for these chemicals.
Keyword:
DATABASE
ACCESS
ATLAS
期刊
IF:
13.1
论文数:
3.6W
被引数:
29.0W
机构
引用论文
The Bgee suite: integrated curated expression atlas and comparative transcriptomics in animals
NUCLEIC ACIDS RESEARCH
IF13.1
2022 updates to the Rat Genome Database: a Findable, Accessible, Interoperable, and Reusable (FAIR) resource
GENETICS
IF5.1
DrugBank 6.0: the DrugBank Knowledgebase for 2024DrugBank 6.0: 2024的DrugBank知识库
NUCLEIC ACIDS RESEARCH
IF13.1
The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources基因策展联盟: 协调基因疾病证据资源的全球努力
GENETICS IN MEDICINE
IF6.2

